Poseida’s P-BCMA-101 Eliminates Tumors in Mice with Multiple Myeloma, Studies Show – Myeloma Research News
Myeloma Research News |
Poseida's P-BCMA-101 Eliminates Tumors in Mice with Multiple Myeloma, Studies Show
Myeloma Research News Usually, CAR T-cells are engineered to express an antibody that recognizes the cancer protein. Poseida has developed a new approach that it believes is more stable and less immunogenic — that is, doesn't induce immune responses against the engineered … |
